ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Shanghai-based CataX AI raises RMB 40 million seed funding from Qiming Venture Partners to deploy AI agents in clinical drug development. The company utilizes a Clinical-of-One model where human experts make key decisions while AI handles data processing and document drafting.
Tap to vote and see what everyone thinks.
Summary by ByteBrief